Lessening the number of people who smoke cigarettes has been an endeavor of the medical community for years now. Significant investment and R&D have gone into developing solutions and safer alternatives for smokers, and big tobacco companies are starting to see that they should shift with the times.

In a recent announcement, Malboro cigarette makers Altria Group Inc. (NYSE:MO) have entered into an agreement to fund R&D of Lexaria Bioscience’s (CSE:LXX,OTCQX:LXRP) DehydraTECH™technology. Altria’s subsidiary, Altria Ventures, has agreed to invest US$12 million in a minority interest of the biotech company’s Lexaria Nicotine LLC division. The money will fund milestone-based clinical investigations utilizing DehydraTECH, with the goal of developing regulatory compliant, oral forms of nicotine delivery. This would make nicotine delivery much safer for consumers.


According to a recent Forbes article on the partnership, Lexaria’s solution is a “completely different, non-combustion-based, non-inhalation-based method which requires no chemicals or additives. Nor is it a nicotine gum or a patch.”

“We use a patented dehydration synthesis process to combine the nicotine with simple ingredients like sunflower oil in a unique way,” Lexaria CEO Chris Bunka explains.” It allows for the removal of the bitter taste often associated with nicotine without the need for artificial flavors that are often appealing to children. Moreover, tested in animals in 2018, we proved that Dehydratech could deliver nicotine to the bloodstream of an animal in as little as two minutes. The fact that it is fast means that smokers might not be frustrated waiting for their nicotine experience to begin, the way they have been with traditional nicotine products such as gums and lozenges.”

Bunka sees Altria’s commitment to this emerging technology as a decision to adapt to the shifting demands of the consumer market. “It means we have to examine whether their company is selling tobacco from a traditional point of view or selling an ‘experience’ from the new-age viewpoint,” he said. “I happen to believe they have come around to realizing they are selling an experience, just like alcohol, cannabis, and coffee. Once the experience –including mild euphoria and increased cognition– is separated from the delivery method, it looks a little different.”

To read the full article, click here.

Click here to connect with Lexaria Bioscience Corp. (CSE:LXX,OTCQB:LXRP) for an Investor Presentation.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less